GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

Boston Scientific Co. (NYSE:BSX – Get Free Report) has been given an average recommendation of “Buy” by the twenty-three ...

Boston Scientific (NYSE:BSX – Get Free Report) had its price objective lifted by equities research analysts at Raymond James ...

New Delhi, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The global neurostimulation devices market was valued at US$ 9.84 billion in 2024 and is expected to reach US$ 22.64 billion by 2033 from, growing at a ...

BD announced it would split from its biosciences and diagnostics unit, while Zimmer Biomet updated investors on its $1.1 ...

Canaccord Genuity maintained a Buy rating with a $101.00 price target for Globus Medical (NYSE:GMED) shares, which currently trades at $88.54. The firm's analysis supports the company's ongoing ...

New research suggests that electrical spinal cord stimulation could improve muscle function for patients who have spinal ...

Daily electrical stimulation of certain nerves in the spinal cord appeared to help three people with spinal muscular atrophy (SMA), an inherited disorder that causes muscles to waste away.